July 8, 2025 · Form 4 insider transaction
Leyman Barbara bought 25,000 shares of Sutro Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 49 days after the transaction.